Literature DB >> 19926800

Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

Rajendra S Kadam1, Uday B Kompella.   

Abstract

In vitro bovine eye tissue/phosphate-buffered saline, pH 7.4, partition coefficients (Kt:b), in vitro binding to natural melanin, and in vivo delivery at 1 h after posterior subconjunctival injection in Brown Norway rats were determined for eight beta-blockers. The Kt:b was in the order intact tissue, dry weight method >or= intact tissue, wet weight method corrected for tissue water and drug in tissue water >> intact tissue, wet weight method > homogenized tissue. In intact tissue methods, Kt:b followed the order choroid-retinal pigment epithelium (RPE) > trabecular meshwork > retina > sclera approximately optic nerve; propranolol > betaxolol > pindolol approximately timolol approximately metoprolol > sotalol approximately atenolol approximately nadolol. Intact tissue, wet weight log (Kt:b) correlated positively with log D for all tissues (R(2) of 0.7-0.9). Log (melanin binding capacity) correlated positively with choroid-RPE log (Kt:b) (R(2) of 0.5). With an increase in concentration, Kt:b decreased in trabecular meshwork for all beta-blockers and for some lipophilic beta-blockers in choroid-RPE and sclera. With an increase in drug lipophilicity, in vivo tissue distribution increased in choroid-RPE, iris-ciliary body, sclera, and cornea but exhibited a declining trend in retina, vitreous, and lens. In vitro bovine intact tissue, wet weight Kt:b correlated positively with rat in vivo tissue/vitreous humor distribution for sclera, choroid-RPE, and retina (R(2) of 0.985-0.993). In vitro tissue partition coefficients might be useful in predicting in vivo drug distribution after trans-scleral delivery. Less lipophilic solutes exhibiting limited nonproductive binding in choroid-RPE might exhibit greater trans-scleral delivery to the retina and vitreous.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926800      PMCID: PMC2835449          DOI: 10.1124/jpet.109.161570

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide.

Authors:  Toshiaki Kubota; Hakuoh Okabe; Toshio Hisatomi; Keita Yamakiri; Taiji Sakamoto; Akihiko Tawara
Journal:  J Glaucoma       Date:  2006-04       Impact factor: 2.503

2.  Simultaneous determination of pKa and lipophilicity by gradient RP HPLC.

Authors:  Paweł Wiczling; Piotr Kawczak; Antoni Nasal; Roman Kaliszan
Journal:  Anal Chem       Date:  2006-01-01       Impact factor: 6.986

Review 3.  The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery.

Authors:  Nicola F Smith; Florence I Raynaud; Paul Workman
Journal:  Mol Cancer Ther       Date:  2007-02       Impact factor: 6.261

4.  Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir.

Authors:  Soumyajit Majumdar; Viral Kansara; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2006-08       Impact factor: 2.671

5.  Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.

Authors:  Aniruddha C Amrite; Surya P Ayalasomayajula; Narayan P S Cheruvu; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

6.  Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.

Authors:  Narayan P S Cheruvu; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

7.  Effect of eye pigmentation on transscleral drug delivery.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

8.  Modeling of corneal and retinal pharmacokinetics after periocular drug administration.

Authors:  Aniruddha C Amrite; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

9.  Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists.

Authors:  Yi-Ning Chen; Hideyuki Yamada; Wei Mao; Shigemi Matsuyama; Makoto Aihara; Makoto Araie
Journal:  Brain Res       Date:  2007-02-22       Impact factor: 3.252

10.  Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.

Authors:  Aniruddha C Amrite; Henry F Edelhauser; Swita R Singh; Uday B Kompella
Journal:  Mol Vis       Date:  2008-01-29       Impact factor: 2.367

View more
  23 in total

1.  In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment.

Authors:  Paul Missel; James Chastain; Ashim Mitra; Uday Kompella; Viral Kansara; Sridhar Duvvuri; Aniruddha Amrite; Narayan Cheruvu
Journal:  J Ocul Pharmacol Ther       Date:  2010-04       Impact factor: 2.671

2.  Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.

Authors:  Rajendra S Kadam; Narayan P S Cheruvu; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

3.  Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes.

Authors:  Chandrasekar Durairaj; James E Chastain; Uday B Kompella
Journal:  Exp Eye Res       Date:  2012-03-13       Impact factor: 3.467

4.  Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids.

Authors:  Ashish Thakur; Rajendra S Kadam; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2011-02-23       Impact factor: 3.922

5.  Influence of permeant lipophilicity on permeation across human sclera.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2010-08-24       Impact factor: 4.200

6.  Brain mitochondrial drug delivery: influence of drug physicochemical properties.

Authors:  Shelley A Durazo; Rajendra S Kadam; Derek Drechsel; Manisha Patel; Uday B Kompella
Journal:  Pharm Res       Date:  2011-07-28       Impact factor: 4.200

7.  Intravitreal Poly(L-lactide) Microparticles Sustain Retinal and Choroidal Delivery of TG-0054, a Hydrophilic Drug Intended for Neovascular Diseases.

Authors:  Namdev B Shelke; Rajendra Kadam; Puneet Tyagi; Vidhya R Rao; Uday B Kompella
Journal:  Drug Deliv Transl Res       Date:  2011-02       Impact factor: 4.617

8.  The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.

Authors:  Wennan Du; Shumao Sun; Yu Xu; Jie Li; Chunhui Zhao; Bifei Lan; Hao Chen; Lingyun Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2013-04-18       Impact factor: 2.671

9.  Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier.

Authors:  Rajendra S Kadam; Robert I Scheinman; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-10-15       Impact factor: 4.939

10.  Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Authors:  Rajendra S Kadam; Preveen Ramamoorthy; Daniel J LaFlamme; Timothy A McKinsey; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-05-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.